| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ZEB1_0007600 | Exon-Intron | chr10:31644076-31680153 | chr10:31355147-31391224 | 250 nt | 0.3320 |
| hsa_ZEB1_0008600 | Exon-Intron | chr10:31644076-31686083 | chr10:31355147-31397154 | 46 nt | 0.3478 |
| hsa_ZEB1_0007700 | Exon-Intron | chr10:31644076-31690436 | chr10:31355147-31401507 | 250 nt | 0.3480 |
| hsa_ZEB1_0008700 | Exon-Intron | chr10:31644076-31709678 | chr10:31355147-31420749 | 135 nt | 0.3852 |
| hsa_ZEB1_0007800 | Exon-Intron | chr10:31644076-31714071 | chr10:31355147-31425142 | 250 nt | 0.3080 |
| hsa_ZEB1_0008800 | Exon-Intron | chr10:31644076-31750166 | chr10:31355147-31461237 | 247 nt | 0.4130 |
| hsa_ZEB1_0008900 | Exon-Intron | chr10:31644076-31757459 | chr10:31355147-31468530 | 46 nt | 0.3478 |
| hsa_ZEB1_0009000 | Exon-Exon | chr10:31644076-31784767 | chr10:31355147-31495838 | 343 nt | 0.4344 |
| hsa_ZEB1_0009100 | Exon-Exon | chr10:31644076-31791437 | chr10:31355147-31502509 | 472 nt | 0.4386 |
| hsa_ZEB1_0009200 | Exon-Intron | chr10:31644098-31676727 | chr10:31355169-31387798 | 103 nt | 0.3398 |
A study in humans identified the circZEB1 as a potential biomarker for immune-mediated demyelinating disease, where its levels in cerebrospinal fluid exosomes were specifically validated [Misir et al. DOI:10.1038/s41418-022-00948-7]. A study in humans demonstrated that circZEB1 was upregulated in left atrial appendages of patients with atrial fibrillation [Tian et al. DOI:10.3390/molecules26041155].